UIH Technologies recalled 3 units of its uMI 780 MD system on September 12, 2025. The device can trap third-party covers, causing table movement interference. Healthcare providers must stop using the device immediately and follow recall instructions.
Third-party outer covers can become trapped between patient table and gantry, causing mechanical interference during table movement.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact UIH Technologies LLC or your healthcare provider for instructions. Notification method: Letter
The recalled product is the Positron Emission Tomography and Computed Tomography System, Model: uMI 780 MD. The affected units include serial numbers 300072, 300082, and 300098. The devices were distributed in the U.S.
Third-party outer covers can become trapped between the patient table and gantry. This can lead to mechanical interference during table movement, posing a high risk to patient safety.
No specific incidents or injuries have been reported. However, the potential for mechanical interference presents a significant risk.
Stop using the uMI 780 MD system immediately. Follow the recall instructions provided by UIH Technologies LLC. Contact the manufacturer or your healthcare provider for further instructions.
For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0224-2026.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.